Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Total 13F shares
-
41,553,043
-
Share change
-
+806,859
-
Total reported value
-
$12,963,955,236
-
Put/Call ratio
-
61%
-
Price per share
-
$312.11
-
Number of holders
-
468
-
Value change
-
+$251,293,533
-
Number of buys
-
194
-
Number of sells
-
221
Institutional Holders of ABIOMED INC - COMMON STOCK (ABMD) as of Q2 2021
As of 30 Jun 2021,
ABIOMED INC - COMMON STOCK (ABMD) was held by
468 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
41,553,043 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., BAILLIE GIFFORD & CO, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, PRIMECAP MANAGEMENT CO/CA/, RENAISSANCE TECHNOLOGIES LLC, BROWN CAPITAL MANAGEMENT LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, and CREDIT SUISSE AG/.
This page lists
468
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.